| __timestamp | Axsome Therapeutics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 4241601.57 |
| Thursday, January 1, 2015 | 2419289 | 5392385.38 |
| Friday, January 1, 2016 | 6343648 | 7370036.73 |
| Sunday, January 1, 2017 | 7206691 | 14970357 |
| Monday, January 1, 2018 | 9351522 | 31413266 |
| Tuesday, January 1, 2019 | 13598030 | 72279461 |
| Wednesday, January 1, 2020 | 28896749 | 183907682 |
| Friday, January 1, 2021 | 66646205 | 307644000 |
| Saturday, January 1, 2022 | 159253661 | 472132000 |
| Sunday, January 1, 2023 | 323123000 | 709539000 |
| Monday, January 1, 2024 | 411359000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. Over the past decade, argenx SE and Axsome Therapeutics, Inc. have shown distinct trajectories in their SG&A spending. Starting in 2014, argenx SE's expenses were nearly three times those of Axsome, reflecting its aggressive expansion strategy. By 2023, argenx SE's SG&A expenses surged to over 700% of their 2014 levels, indicating a robust investment in operational capabilities. In contrast, Axsome's expenses grew more steadily, reaching approximately 230 times their initial value by 2023. This divergence highlights argenx's rapid scaling approach compared to Axsome's more measured growth. Understanding these trends offers valuable insights into each company's strategic priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Takeda Pharmaceutical Company Limited and argenx SE
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
Selling, General, and Administrative Costs: argenx SE vs Dr. Reddy's Laboratories Limited
argenx SE and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing argenx SE and ADMA Biologics, Inc.
argenx SE and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
argenx SE or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Walgreens Boots Alliance, Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Axsome Therapeutics, Inc. or Rhythm Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. vs ImmunityBio, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.